日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming acquired immunotherapy resistance in non-small cell lung cancer using ginsenoside Rb1-loaded, peptide-enhanced exosome delivery systems

利用载有Rb1人参皂苷、肽增强的外泌体递送系统克服非小细胞肺癌的获得性免疫治疗耐药性

Xiangyuan Jin ,Tanghesi Wuyun ,Yu Zhang ,Xiaohong Wang ,Ling Zhao

Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs

转移性小细胞肺癌起源于TP53/RB1缺陷和MYC过度表达的hESC衍生PNEC。

Huanhuan Joyce Chen # ,Eric E Gardner # ,Yajas Shah ,Kui Zhang ,Abhimanyu Thakur ,Chen Zhang ,Olivier Elemento ,Harold Varmus

Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation

人参皂苷Rb1通过调节NETs诱导的内皮细胞活化过程中FTO介导的m6A RNA修饰,部分缓解动脉粥样硬化。

Zhenni Yang ,Minqi Xiong ,Xinmiao Tang ,Peiwei Wang ,Jingang Cui ,Yu Chen ,Teng Zhang

Overexpression of hsa-HLA-DRB1 may delay diabetic wound healing and angiogenesis by regulating miRNA_12118 and FLT-1

hsa-HLA-DRB1 的过度表达可能通过调节 miRNA_12118 和 FLT-1 来延缓糖尿病伤口愈合和血管生成。

Chao Bai # ,Wenwen Yang # ,Jianghao Yan ,Guangwei Qi ,Liuyu Yang ,Qingrui Wu ,Jieguang Peng ,Jun Luo ,Tao Liu

Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis

白细胞免疫球蛋白样受体B1(LILRB1)通过维持胆固醇稳态来保护人类多发性骨髓瘤细胞免受铁死亡的影响

Miao Xian # ,Qiang Wang # ,Liuling Xiao ,Ling Zhong ,Wei Xiong ,Lingqun Ye ,Pan Su ,Chuanchao Zhang ,Yabo Li ,Robert Z Orlowski ,Fenghuang Zhan ,Siddhartha Ganguly ,Youli Zu ,Jianfei Qian ,Qing Yi

HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease

HLA-DQB1*05 亚型而非 DRB1*10:01 介导抗 IgLON5 疾病的风险

Selina M Yogeshwar,Sergio Muñiz-Castrillo,Lidia Sabater,Vicente Peris-Sempere,Vamsee Mallajosyula,Guo Luo,Han Yan,Eric Yu,Jing Zhang,Ling Lin,Flavia Fagundes Bueno,Xuhuai Ji,Géraldine Picard,Véronique Rogemond,Anne Laurie Pinto,Anna Heidbreder,Romana Höftberger,Francesc Graus,Josep Dalmau,Joan Santamaria,Alex Iranzo,Bettina Schreiner,Maria Pia Giannoccaro,Rocco Liguori,Takayoshi Shimohata,Akio Kimura,Yoya Ono,Sophie Binks,Sara Mariotto,Alessandro Dinoto,Michael Bonello,Christian J Hartmann,Nicola Tambasco,Pasquale Nigro,Harald Prüss,Andrew McKeon,Mark M Davis,Sarosh R Irani,Jérôme Honnorat,Carles Gaig,Carsten Finke,Emmanuel Mignot

LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

LILRB1-HLA-G轴定义了结核病中驱动自然杀伤细胞耗竭的检查点

Jing Wang # ,Qiyao Chai # ,Zehui Lei # ,Yiru Wang # ,Jiehua He # ,Pupu Ge ,Zhe Lu ,Lihua Qiang ,Dongdong Zhao ,Shanshan Yu ,Changgen Qiu ,Yanzhao Zhong ,Bing-Xi Li ,Lingqiang Zhang ,Yu Pang ,George Fu Gao ,Cui Hua Liu

Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer

在非小细胞肺癌中,向小细胞肺癌的转化与EGFR无关,并且由SMAD4介导的ASCL1转录加速,而该过程独立于RB1。

Xi Ding # ,Min-Xing Shi # ,Di Liu # ,Jing-Xue Cao ,Kai-Xuan Zhang ,Run-Dong Zhang ,Li-Ping Zhang ,Kai-Xing Ai ,Bo Su ,Jie Zhang

A functional schizophrenia-associated genetic variant near the TSNARE1 and ADGRB1 genes

TSNARE1 和 ADGRB1 基因附近存在一种与精神分裂症相关的功能性遗传变异

Marah H Wahbeh ,Rachel J Boyd ,Christian Yovo ,Bailey Rike ,Andrew S McCallion ,Dimitrios Avramopoulos

MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer

MYBL2驱动前列腺癌可塑性:抑制其转录靶点CDK2以治疗RB1缺陷型神经内分泌前列腺癌

Beatriz German ,Sarah A Alaiwi ,Kun-Lin Ho ,Jagpreet S Nanda ,Marcos A Fonseca ,Deborah L Burkhart ,Anjali V Sheahan ,Hannah E Bergom ,Katherine L Morel ,Himisha Beltran ,Justin H Hwang ,Matthew L Freedman ,Kate Lawrenson ,Leigh Ellis